Niwropatholeg Cymru Cyf 14754884 false 2025-04-01 2026-03-31 2026-03-31 The principal activity of the company is Neuropathology Digita Accounts Production Advanced 6.30.9574.0 true true 14754884 2025-04-01 2026-03-31 14754884 2026-03-31 14754884 bus:OrdinaryShareClass1 2026-03-31 14754884 bus:OrdinaryShareClass2 2026-03-31 14754884 bus:OrdinaryShareClass3 2026-03-31 14754884 core:RetainedEarningsAccumulatedLosses 2026-03-31 14754884 core:ShareCapital 2026-03-31 14754884 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 14754884 core:OfficeEquipment 2026-03-31 14754884 bus:SmallEntities 2025-04-01 2026-03-31 14754884 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 14754884 bus:FullAccounts 2025-04-01 2026-03-31 14754884 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 14754884 bus:RegisteredOffice 2025-04-01 2026-03-31 14754884 bus:Director1 2025-04-01 2026-03-31 14754884 bus:OrdinaryShareClass1 2025-04-01 2026-03-31 14754884 bus:OrdinaryShareClass2 2025-04-01 2026-03-31 14754884 bus:OrdinaryShareClass3 2025-04-01 2026-03-31 14754884 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 14754884 core:OfficeEquipment 2025-04-01 2026-03-31 14754884 countries:AllCountries 2025-04-01 2026-03-31 14754884 2025-03-31 14754884 core:OfficeEquipment 2025-03-31 14754884 2024-04-01 2025-03-31 14754884 2025-03-31 14754884 bus:OrdinaryShareClass1 2025-03-31 14754884 bus:OrdinaryShareClass2 2025-03-31 14754884 bus:OrdinaryShareClass3 2025-03-31 14754884 core:RetainedEarningsAccumulatedLosses 2025-03-31 14754884 core:ShareCapital 2025-03-31 14754884 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 14754884 core:OfficeEquipment 2025-03-31 iso4217:GBP xbrli:pure xbrli:shares

Filleted

Registration number: 14754884

Niwropatholeg Cymru Cyf
Annual Report and Unaudited Financial Statements
for the Year Ended 31 March 2026

Niwropatholeg Cymru Cyf

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Financial Statements | 3 to 6

Niwropatholeg Cymru Cyf

Company Information

Director | Dr A R Daniels

Registered office | Llys Deri Parc Pensarn Carmarthen SA31 2NF

Niwropatholeg Cymru Cyf

(Registration number: 14754884)
Balance Sheet as at 31 March 2026

| Note | 2026 £ | 2025 £
Fixed assets |  |  |
Tangible assets | 5 | 542 | 209
Current assets |  |  |
Cash at bank and in hand |  | 7,987 | 10,204
Creditors: Amounts falling due within one year | 6 | (1,850) | (3,036)
Net current assets |  | 6,137 | 7,168
Net assets |  | 6,679 | 7,377
Capital and reserves |  |  |
Called up share capital |  | 102 | 102
Profit and loss account |  | 6,577 | 7,275
Total equity |  | 6,679 | 7,377

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the director on 1 July 2026

......................................... Dr A R Daniels Director |  |

Niwropatholeg Cymru Cyf

Notes to the Financial Statements for the Year Ended 31 March 2026

1 | General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Llys Deri
Parc Pensarn
Carmarthen
SA31 2NF

These financial statements were authorised for issue by the director on 1 July 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Niwropatholeg Cymru Cyf

Notes to the Financial Statements for the Year Ended 31 March 2026

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Office Equipment | 25% Reducing Balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2025 - 1).

4 | Profit before tax

Arrived at after charging/(crediting)

| 2026 £ | 2025 £
Depreciation expense | 167 | 70

Niwropatholeg Cymru Cyf

Notes to the Financial Statements for the Year Ended 31 March 2026

5 | Tangible assets

| Office equipment £ | Total £
Cost or valuation
At 1 April 2025 | 319 | 319
Additions | 500 | 500
At 31 March 2026 | 819 | 819
Depreciation
At 1 April 2025 | 110 | 110
Charge for the year | 167 | 167
At 31 March 2026 | 277 | 277
Carrying amount
At 31 March 2026 | 542 | 542
At 31 March 2025 | 209 | 209

6 | Creditors

Creditors: amounts falling due within one year

| Note | 2026 £ | 2025 £
Due within one year |  |  |
Taxation and social security |  | 105 | 1,698
Directors' loan accounts | 8 | 1,085 | 708
Other creditors |  | 660 | 630
|  | 1,850 | 3,036

Niwropatholeg Cymru Cyf

Notes to the Financial Statements for the Year Ended 31 March 2026

7 | Share capital

Allotted, called up and fully paid shares

| 2026 | 2025
| No. | £ | No. | £
A Ordinary of £1 each | 100 | 100 | 100 | 100
B Ordinary of £1 each | 1 | 1 | 1 | 1
C Ordinary of £1 each | 1 | 1 | 1 | 1
| 102 | 102 | 102 | 102

8 | Related party transactions

Transactions with directors

As at the balance sheet date, the director was owed £1,085 (2025 : £708) from the company. The loan is interest free and repayable on demand.